Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 6,600 shares at $1.58 ($10K) on 2021-12-08, disclosed to the SEC on 2021-12-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.49 | 1,500 | $2K | 21.4% |
| 2 | $1.55 | 1,900 | $3K | 28.2% |
| 3 | $1.58 | 1,200 | $2K | 18.1% |
| 4 | $1.69 | 2,000 | $3K | 32.3% |
| Total | $1.58 avg | 6,600 | $10K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |